Luprac (TN) en es it fr

Luprac (TN) Brand names, Luprac (TN) Analogs

Luprac (TN) Brand Names Mixture

  • No information avaliable

Luprac (TN) Chemical_Formula


Luprac (TN) RX_link

Luprac (TN) fda sheet

Luprac (TN) msds (material safety sheet)

Luprac_(TN) MSDS

Luprac (TN) Synthesis Reference

No information avaliable

Luprac (TN) Molecular Weight

348.421 g/mol

Luprac (TN) Melting Point

163-164 oC (decomposition)

Luprac (TN) H2O Solubility


Luprac (TN) State


Luprac (TN) LogP


Luprac (TN) Dosage Forms

Liquid; Tablet

Luprac (TN) Indication

For the treatment of hypertension, edema induced by congestive heart failure or renal disease, and ascites associated with hepatic disease.

Luprac (TN) Pharmacology

Torasemide, a monosulfonamyl loop diuretic, differs form other thiazide diuretics in that a double ring system is incorporated into its structure. Torasemide is used alone or with atenolol in the management of hypertension and edema. Micropuncture studies in animals have shown that torsemide acts from within the lumen of the thick ascending portion of the loop of Henle, where it inhibits the Na+/K+/2Cl--carrier system.

Luprac (TN) Absorption

Bioavailability is approximately 80%. Serum concentration peaks after approximately 1 hour.

Luprac (TN) side effects and Toxicity

LD50 = 5 g/kg (rat, oral), 500 mg/kg (rat, intravenous). Side effects include dizziness, headache, nausea and vomiting.

Luprac (TN) Patient Information

No information avaliable

Luprac (TN) Organisms Affected

Humans and other mammals